Does the prevalence of the metabolic syndrome improve by applying the International Diabetes Federation criteria?

Public Health Nutrition

Volumn 10, Issue 10 A, 2007, Pages 1173-1180

  Soto Gonzalez A ^a   Bellido Guerrero, D ^a   Buno Soto M ^a   Pertega Diaz S ^a   De Luis, D ^b   Lopez De La Torre, M ^c   Martinez Olmos M ^d  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b Hospital Juan Canalejo ^*  (Spain)

^c HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^d Hospital Mexoeiro   (Spain)

Author keywords

Definition of the metabolic syndrome; Insulin resistance; Prevalence

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; ENDOCRINOLOGY; FEMALE; HUMAN; INTERNATIONAL COOPERATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTORS; SEX FACTORS; SPAIN; TERMINOLOGY AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 36049034250     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980007000675     Document Type: Article

References (39)

1. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41(6): 715-22.
2. Isomaa B, Almgren P, Tuomi T, Forse0n B, Lahti K, Nisse'n M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24(5): 683-9.
3. Reaven GM. Banting lecture 1988: role of insulin resitance in human disease. Diabetes 1988; 37(12): 1595-607.
4. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. American Journal of Cardiology 1999; 83(9B): 25F-9F.
5. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Geneva: Department of Non-communicable Disease Surveillance, World Health Organization, 1999.
6. Balkau B, Charles MA, Comment on the provisional report from the WHO consultation. European Group for Study of Insulin Resistance (EGIR). Diabetic Medicine 1999; 16(5): 442-3.
7. Expert Panel on Detection. Evaluation and treatment of high blood cholesterol in adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of the American Medical Association 2001; 285(19): 2486-97.
8. American College of Endocrinology Task Force on the Insulin Resistance Sídrome. American College of Endocrinology Position Statement on the insulin resistance syndrome. Endocrine Practice 2002; 9(1): 236-52.
9. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Diabetes Care 2005; 28(5): 2289-304.
10. International Diabetes Federation. Worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_Metasyndrome definition.pdf. Accessed August 24, 2005.
11. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. A metabolic syndrome in whites and African-Americans: the Atherosclerosis Risk in Communities Baseline Study. Diabetes care 1996; 19(5): 414-18.
12. Liese AD, Mayer-Davis EJ, Trroler HA, Davis CE, Keil U, Scmidt MI, et al. Familial components of the multiple metabolic síndrome: the ARIC study. Diabetología 1997; 40(8): 963-70.
13. Álvarez León EE, Ribas Barba L, Serra Majem L. Prevalencia del síndrome metabólico en la población de las Islas Canarias. Medicina Clinica (Barcelona) 2003; 120(5): 172-4.
14. Hernández A, Riera C, Solá E, Oliver MJ, Martínez ML, Morillas C, et al. Prevalencia del síndrome metabólico entre pacientes con cardiopatía isquémica. Medicina Clinica (Barcelona) 2003; 121(6): 204-8.
15. Ascaso JF, Romero P, Real JT, Lorente RI, Martínez-Valls J, Carmena R. Abdominal obesity, insulin resistance, and metabolic syndrome in a Southern European population. European Journal of Internal Medicine 2003; 14(2): 101-6.
16. Alvarez Cosmea A, López Fernández V, Suárez García S, Arias García T, Prieto Díaz MA, Díaz González L. Diferencias en la prevalencia del síndrome metabólico según las definiciones del ATP III y la OMS. Medicina Clinica (Barcelona) 2005; 124(10): 368-70.
17. WHO Consultation on obesity. Preventing and managing the global epidemic. Geneva: WHO, 1998.
18. Allain CC, Poon LS, Chan CSG, Richmod WPC. Enzymatic determination of total serum cholesterol. Clinical Chemistry 1979; 20(4): 470-5.
19. Ter HF, Baarscheer T, Fiolet JWT. Influence of free glycerol on enzymatic of triglycerides. Clinical Chemistry 1984; 30(6): 1102-3.
20. Trinder P. Enzymatic colorimetric method for glucose determination. Annals Of Clinical Biochemistry 1969; 6(4): 24-7.
21. Berson S, Yellow RS. Quantitative aspects of the reaction between insulin and insulin-binding antibody. Journal of Clinical Investigation 1959; 38: 1996-2016.
22. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, et al. The rising prevalence of diabetes and impaired glucose tolerance. The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25(5): 829-34.
23. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109(3): 433-8.
24. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 2004; 27(10): 2444-9.
25. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Archives of Internal Medicine 2004; 164(10): 1066-76.
26. Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, et al. Report of the American Diabetes Association's task force on standardization of the insulin assay. Diabetes 1996; 45(2): 242-56.
27. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2005; 28(Suppl. 1): S37-42.
28. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 2002; 288(21): 2709-16.
29. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28(2): 385-90.
30. Grundy SM, Cleeman JI, Daniel SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association. National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome. Circulation 2005; 112(17): 2735-52.
31. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Diabetes Care 2005; 28(9): 2289-304.
32. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. American Journal of Epidemiology 2002; 156(11): 1070-7.
33. Resnick HE. Metabolic syndrome in American Indians. Diabetes Care 2002; 25(7): 1246-7.
34. Adrian J Cameron, Timothy A Welborn, Paul Z Zimmet, David W Dunstan, Neville Owen, Jo Salmon, et al. Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). The Medical Journal of Australia 2003; 178(9): 427-32.
35. Cameron AJ, Shaw JE, Zimmet PZ, Chitson P, Alberti KGGM, Toumiletho J. Comparison of WHO and NCEP metabolic syndrome definitions over 5 years in Mauritius. Diabetología 2003; 46(2): A3068.
36. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The Metabolic Syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Archives of Internal Medicine 2003; 163(1): 427-36.
37. Palaniappan L, Carnethon MR, Wang Y, Hanley AJ, Fortmann SP, Haffner SM, et al. Insulin Resistance Atherosclerosis Study. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27(3): 788-93.
38. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. British Medical Journal 1995; 311(7017): 1401-5.
39. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. British Medical Journal 1995; 311(6998): 158-61.